Inhibition of Simian Virus 40 replication by targeting the molecular chaperone function and ATPase activity of T

Christine M Wright1, Sandlin P Seguin, Sheara W Fewell

  • 1Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.

Virus Research
|February 10, 2009
PubMed

Insights

A novel compound, MAL2-11B, effectively inhibits polyomavirus replication by targeting the viral large tumor antigen

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Polyomaviruses, including BK virus and JC virus, are associated with diseases, yet effective antiviral treatments are scarce due to challenges in virus culturing.
  • Simian Virus 40 (SV40) replication is well-understood and serves as a model for studying polyomavirus replication mechanisms.

Purpose of the Study:

  • To identify small molecules that can inhibit polyomavirus replication.
  • To investigate the potential of targeting viral large tumor antigen (TAg) chaperone and ATPase activities for antiviral therapy.

Main Methods:

  • Screening a library of small molecules for inhibitors of SV40 replication.
  • Assessing the effect of compounds on TAg's ATPase activity and Hsp70 chaperone activation.
  • Evaluating viral propagation and DNA replication in cell culture and in vitro.
  • Testing compound efficacy against BK virus in human kidney cells.

Main Results:

  • One compound, MAL2-11B, demonstrated inhibition of TAg's ATPase activity and Hsp70 activation.
  • MAL2-11B significantly reduced SV40 propagation and DNA replication.
  • The compound also effectively inhibited BK virus growth in human kidney cells.

Conclusions:

  • Pharmacological inhibition of TAg's chaperone and ATPase activities is a viable strategy for developing novel antiviral treatments against polyomaviruses.
  • MAL2-11B shows promise as a potential therapeutic agent for polyomavirus infections.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...